Topic Archives: Licensing + Commercial

October 1, 2019 - Asia, Biotech, Intellectual Property, Licensing + Commercial, Regulatory

China Patent Eligibility Update: Human Embryonic Stem Cells

By: Can Cui

On September 23, 2019, China National Intellectual Property Administration (“CNIPA”) announced its proposed amendments to China’s Guideline on Patent Examination (the “Guideline”), which is the counterpart of the Manual of Patent Examining Procedure in the U.S. The proposed amendments will become effective November …›

August 1, 2017 - European Union, Licensing + Commercial, Regulatory

IP Licensing and Antitrust Law – What Companies Have to Consider When Doing Business in the U.S. and the EU

By: Jens Hackl, Wolfgang Schönig, and Jeff Jaeckel

In both the U.S. and the EU, it is generally acknowledged that the enforcement and commercialization of IP rights must comply with the applicable antitrust laws. This is particularly true for IP licensing. While the majority of provisions in license arrangements will not be …›